Main Page | Risk Factors | Reducing Your Risk | Screening | Symptoms | Diagnosis | Treatment Overview | Chemotherapy | Other Treatments | Lifestyle Changes | Managing Side Effects | | Talking to Your Doctor | Resource Guide
At this time, traditional chemotherapy protocols are not effective for treating MDS. High-dose chemotherapy may be used before a stem cell transplant to rid the body of cancer cells. It may also be used for MDS that has progressed to acute myeloid leukemia or to relieve symptoms associated with the disease. If chemotherapy is used, it does not offer a cure.
There are three combinations of chemotherapy drugs used to treat MDS. These combinations include:
Chemotherapy for MDS is usually given through an IV, but some forms can be injected under the skin. It is delivered in cycles over a set period of time. A medical oncologist will determine how many cycles of chemotherapy are needed and what combination of drugs will work best. It is not unusual for a relapse to occur after treatment. If so, the combination of chemotherapy drugs be changed.
Though the drugs are targeted to cancer cells, they can affect healthy cells as well. The death of cancer cells and impact on healthy cells can cause a range of side effects. A medical oncologist will work to find the best drug combination and dosage to have the most impact on the cancer cells and minimal side effects on healthy tissue. Side effects or complications from chemotherapy may include:
A variety of treatments are available to help manage side effects including medication, lifestyle changes, and alternative treatments. In some cases, the chemotherapy regimen may be adjusted to reduce severe side effects. The earlier the side effects are addressed, the more likely they will be controlled with a minimum of discomfort.
Chemotherapy for myelodysplastic syndromes. American Cancer Society website. Available at: https://www.cancer.org/cancer/myelodysplastic-syndrome/treating/chemotherapy.html. Updated February 10, 2014. Accessed June 30, 2016.
Cytarabine. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T233106/Cytarabine. Updated June 16, 2017. Accessed June 30, 2017.
Myelodysplastic syndrome. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114054/Myelodysplastic-syndrome-MDS. Updated January 13, 2017. Accessed June 30, 2017.
Treatment option overview. National Cancer Institute website. Available at: https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq#section/_49. Updated August 12, 2015. Accessed June 30, 2017.
Last reviewed June 2017 by EBSCO Medical Review Board Mohei Abouzied, MD, FACP
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×